Tomoko Yanai
4PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 27, 2023
Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study.Yasutoshi Kuboki, Toshio Shimizu, Kan Yonemori
|Apr 12, 2022
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.Toshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin
|Nov 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.Toshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin
|Aug 23, 2019
Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.Noriko Fukuhara, Go Yamamoto, Hideki Tsujimura
Pageof 1
Frequent Collaborators
3 joint publications
Toshio Shimizu
3 joint publications
Yasutoshi Kuboki
3 joint publications
Kan Yonemori
2 joint publications
Kyu-Pyo Kim
2 joint publications
Chia-Chi Lin
2 joint publications
Douglas V Faller
2 joint publications
Lwona Dobler
2 joint publications
Neeraj Gupta
1 joint publications
Noriko Fukuhara
1 joint publications
Hirohiko Shibayama
![Automated Preparation of [<sup>68</sup>Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=75)
